Tag - pfizer

 
 

PFIZER

Japan Times
COMMENTARY / World
Nov 15, 2020
Here’s to the immigrant heroes behind the BioNTech vaccine
Their journey as Turkish Germans cannot have been easy. Discrimination, overt or subtle, is rife in German society.
Japan Times
COMMENTARY / World
Nov 13, 2020
What happens to the other COVID-19 vaccines now?
If the vaccine created by Pfizer and partner BioNTech fails to live up to its promise, will any slower but better competitors have a chance?
Japan Times
WORLD / Science & Health
Nov 12, 2020
Moderna COVID-19 vaccine trial reaches key goal to gauge merit
The bet among top experts in the field is that Moderna's therapy will likely prove to be highly effective.
Japan Times
WORLD / Science & Health / FOCUS
Nov 10, 2020
Why Pfizer’s vaccine won't be at the local pharmacy anytime soon
The vaccine's complex and supercold storage requirements are an obstacle for even the most sophisticated hospitals and may impact when and where it is available.
Japan Times
WORLD / Science & Health
Nov 10, 2020
Pfizer's COVID-19 vaccine trial success signals breakthrough in pandemic battle
The vaccine candidate is more than 90% effective based on initial trial results, the drugmaker said Monday.
Japan Times
WORLD / Science & Health
Sep 18, 2020
COVID-19 vaccine leaders make trial plans public in transparency push
The moves come amid increasing concern that the effort to develop a COVID-19 vaccine is becoming politicized.
Japan Times
WORLD / Science & Health
Sep 16, 2020
Pfizer COVID-19 vaccine trial reports no major safety issues
Safety has been a paramount concern since AstraZeneca paused tests of the vaccine it's co-developing with the University of Oxford following an adverse event in a U.K.
Japan Times
JAPAN / Science & Health
Aug 7, 2020
Japan and AstraZeneca set for deal on 100 million doses of virus vaccine
The drugmaker is expected to begin clinical trials in Japan later this month to confirm the efficacy and safety of its vaccine, currently being tested overseas.
Japan Times
JAPAN / Science & Health
Aug 1, 2020
Japan and Pfizer reach COVID-19 vaccine deal to treat 60 million people
The agreement marks Japan's first advance deal for a vaccine to fight the coronavirus.
Japan Times
BUSINESS / Companies
Jul 14, 2020
Pfizer and BioNTech coronavirus vaccine candidates on FDA fast track
The U.S.-listed shares of the German firm climbed about 15 percent, while Pfizer's stock rose about 5 percent.
WORLD / Science & Health
Dec 9, 2017
Pfizer's breast cancer drug found to be superior to chemotherapy in Phase III study
Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer drug went about three months longer before their disease worsened than those who received chemotherapy in a late-stage study, according to data released Friday.
Japan Times
BUSINESS / Companies
Sep 29, 2017
Opioids demand rises in Japan as seniors use drugs to ease pain and improve quality of life
Selling painkillers in Japan used to be like pulling teeth. That was until baby boomers discovered how analgesics could take the sting from arthritis, diabetic nerve damage and the ravages of cancer.
Japan Times
BUSINESS
Nov 24, 2015
Clinton hits $160 billion Pfizer 'inversion' deal with Allergan, says taxpayers left holding the bag
Democratic presidential front-runner Hillary Rodham Clinton attacked Pfizer Inc.'s plan to move its tax address to Ireland through a merger with Allergan PLC, saying it would hurt U.S. taxpayers and urging a crackdown on such deals.

Longform

Later this month, author Shogo Imamura will open Honmaru, a bookstore that allows other businesses to rent its shelves. It's part of a wave of ideas Japanese booksellers are trying to compete with online spaces.
The story isn't over for Japan's bookstores